华海药业 - Financials

华海药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	9.5B	8.3B	8.3B	6.6B	6.5B
Revenue Growth %	14.9%	0.5%	24.4%	2.5%	--
Total Revenue	9.5B	8.3B	8.3B	6.6B	6.5B
Cost Of Revenue	3.6B	3.3B	3.1B	2.7B	2.4B
+Gross Profit	5.9B	5.0B	5.2B	4.0B	4.1B
Gross Margin %	61.9%	60.4%	62.4%	60.0%	63.7%
Total Operating Cost	8.1B	7.2B	6.8B	6.3B	5.4B
Selling Expenses	1.7B	1.3B	1.2B	1.2B	996.0M
Admin Expenses	1.5B	1.3B	1.3B	1.3B	1.1B
Rd Expenses	987.0M	983.0M	926.0M	942.0M	566.0M
Finance Expenses	95.5M	137.0M	-10.8M	188.0M	265.0M
+Operating Income	1.5B	1.1B	1.5B	868.0M	1.3B
Operating Margin %	15.4%	13.5%	18.7%	13.1%	19.8%
Non Operating Income	10.0M	5.8M	3.6M	951,300	1.6M
Non Operating Expenses	17.1M	30.0M	41.9M	82.4M	72.8M
Investment Income	-28.7M	-62.7M	-75.2M	147.0M	-22.4M
Fair Value Change Income	-69.5M	-100.0M	5.2M	300.0M	48.5M
Asset Disposal Income	2.3M	-289,700	3.6M	602,900	19.2M
Asset Impairment Loss	123.0M	117.0M	70.6M	13.9M	32.8M
Other Income	157.0M	185.0M	99.5M	107.0M	146.0M
Income Before Tax	1.5B	1.1B	1.5B	787.0M	1.2B
Income Tax	356.0M	283.0M	333.0M	306.0M	221.0M
+Net Income	1.1B	817.0M	1.2B	481.0M	995.0M
Net Margin %	11.6%	9.8%	14.2%	7.2%	15.3%
Net Income Attributable	1.1B	830.0M	1.2B	488.0M	930.0M
Minority Interest	-11.5M	-13.2M	8.3M	-6.9M	64.8M
Eps Basic	0.77	0.57	0.81	0.34	0.64
Eps Diluted	0.77	0.57	0.80	0.34	0.64

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	1.5B	1.3B	1.4B	1.9B	2.2B
Trading Financial Assets	60.8M	93.0M	143.0M	1.0M	--
Accounts Receivable	2.9B	2.5B	2.7B	1.9B	1.7B
Notes Receivable	--	--	--	--	--
Notes And Accounts Receivable	2.9B	2.5B	2.7B	1.9B	1.7B
Prepayments	94.9M	61.6M	72.4M	79.3M	68.1M
Inventory	3.4B	3.4B	3.4B	2.7B	2.4B
Total Current Assets	8.5B	7.6B	7.9B	6.8B	6.5B
Long Term Equity Investment	422.0M	418.0M	388.0M	489.0M	445.0M
Fixed Assets	--	5.6B	4.4B	3.4B	--
Fixed Assets Total	6.4B	5.6B	4.4B	3.4B	3.2B
Construction In Progress	--	2.3B	2.8B	2.5B	1.2B
Construction In Progress Total	2.2B	2.3B	2.8B	2.5B	1.2B
Intangible Assets	1.2B	1.1B	1.1B	971.0M	807.0M
Long Term Deferred Expenses	39.9M	46.8M	26.4M	6.4M	8.3M
Total Non Current Assets	11.8B	11.0B	10.2B	8.7B	6.5B
Total Assets	20.3B	18.6B	18.2B	15.5B	13.0B
Short Term Borrowings	2.1B	1.6B	1.4B	1.3B	1.0B
Accounts Payable	990.0M	944.0M	853.0M	527.0M	392.0M
Advance Receipts	--	--	--	--	32,500
Contract Liabilities	54.4M	33.5M	67.7M	66.7M	40.1M
Total Current Liabilities	6.0B	5.4B	4.8B	4.2B	2.9B
Long Term Borrowings	2.5B	2.2B	2.9B	1.8B	1.3B
Total Non Current Liabilities	5.3B	4.9B	5.6B	4.5B	3.4B
Total Liabilities	11.2B	10.3B	10.4B	8.7B	6.3B
Paid In Capital	1.5B	1.5B	1.5B	1.5B	1.5B
Capital Reserve	1.2B	1.3B	1.3B	1.4B	1.0B
Surplus Reserve	746.0M	746.0M	746.0M	709.0M	599.0M
Retained Earnings	5.6B	4.7B	4.2B	3.3B	3.2B
Minority Equity	122.0M	174.0M	199.0M	217.0M	211.0M
Equity Attributable	8.9B	8.1B	7.5B	6.6B	6.5B
Total Equity	9.0B	8.3B	7.7B	6.8B	6.7B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	9.0B	8.6B	7.3B	6.3B	5.8B
Tax Refunds Received	240.0M	240.0M	558.0M	264.0M	205.0M
Total Operating Cash Inflow	9.6B	9.3B	8.1B	6.9B	6.2B
Cash Paid For Goods	2.3B	2.2B	2.6B	2.2B	1.6B
Cash Paid To Employees	1.7B	1.5B	1.3B	1.2B	1.0B
Taxes Paid	809.0M	855.0M	764.0M	492.0M	322.0M
Total Operating Cash Outflow	7.4B	7.1B	6.9B	5.9B	4.6B
Operating Cash Flow	2.2B	2.2B	1.2B	938.0M	1.6B
Total Investing Cash Inflow	31.7M	56.7M	78.4M	235.0M	67.3M
Total Investing Cash Outflow	2.0B	1.7B	2.5B	2.6B	1.4B
Investing Cash Flow	-1.9B	-1.6B	-2.4B	-2.4B	-1.4B
Cash From Borrowings	6.2B	3.3B	3.8B	3.2B	6.1B
Dividends And Interest Paid	507.0M	569.0M	318.0M	407.0M	408.0M
Debt Repayments	5.6B	3.2B	2.7B	1.9B	5.1B
Total Financing Cash Inflow	6.2B	3.3B	3.9B	3.6B	6.1B
Total Financing Cash Outflow	6.3B	4.0B	3.3B	2.5B	5.5B
Financing Cash Flow	-133.0M	-644.0M	609.0M	1.1B	596.0M
Net Change In Cash	171.0M	-21.0M	-526.0M	-344.0M	709.0M
Ending Cash Balance	1.5B	1.3B	1.3B	1.9B	2.2B
Capex	1.9B	1.6B	2.3B	2.4B	1.3B